EvE Bio is a Focused Research Organization (FRO) – a new kind of nonprofit research institution, philanthropically funded to accomplish a single goal, for the public good, over a fixed corporate lifespan.

EvE's goal is to systematically quantify drug-protein interactions within the human druggable proteome via functional assays. This results in a consistently generated and processed dataset which includes both positive and negative results. A new batch of data is released approximately every other month.

EvE Bio acknowledges support from Convergent Research, Eric and Wendy Schmidt, Founders Pledge, and Lyda Hill Philanthropies. We are also grateful to EvE's commercial sponsor, DrugBank.